# Efficacy of Alendronate Versus Placebo in the Treatment of HIV-associated Osteoporosis (ANRS120)

> **NCT00120757** · PHASE3 · COMPLETED · sponsor: **French National Agency for Research on AIDS and Viral Hepatitis** · enrollment: 140 (—)

## Conditions studied

- Osteoporosis
- HIV Infections

## Interventions

- **DRUG:** Alendronate

## Key facts

- **NCT ID:** NCT00120757
- **Lead sponsor:** French National Agency for Research on AIDS and Viral Hepatitis
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 140 (—)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00120757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00120757, "Efficacy of Alendronate Versus Placebo in the Treatment of HIV-associated Osteoporosis (ANRS120)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00120757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*